NDC00143-1025-01: AMINOPHYLLINE TABLETS.
The AMINOPHYLLINE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: W/CHILD-PROOF SAFETY CLOSURE, primary_container_type: BOTTLE, supplementary_features: D-DAY ITEM FOR DOD, therapeutic_equivalent: WEST-WARD, protective_storage_feature: EXPIRATION DATED. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-105-9704, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | W/CHILD-PROOF SAFETY CLOSURE |
| primary_container_type | BOTTLE |
| supplementary_features | D-DAY ITEM FOR DOD |
| therapeutic_equivalent | WEST-WARD |
| protective_storage_feature | EXPIRATION DATED |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 200.000 MILLIGRAMS AMINOPHYLLINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | AMINOPHYLLINE TABLETS USP 200 MG 100 TABLETS PER BOTTLE |
| NSN | 6505-00-105-9704 |
| THERAPEUTIC EQUIVALENT | WEST-WARD |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| SUPPLEMENTARY FEATURES | D-DAY ITEM FOR DOD |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | W/CHILD-PROOF SAFETY CLOSURE |
| PROTECTIVE STORAGE FEATURE | EXPIRATION DATED |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | AMINOPHYLLINE TABLETS USP 200 MG 100 TABLETS PER BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.000 MILLIGRAMS AMINOPHYLLINE ACTIVE INGREDIENT |